Glutamate infusion reduces myocardial dysfunction after coronary artery bypass grafting according to NT-proBNP: summary of two randomized controlled trials (GLUTAMICS I-II)
CONCLUSIONS: Infusion of glutamate reduced postoperative rise in NT-proBNP after CABG in medium to high-risk patients. A significantly blunted effect was observed only in insulin-treated diabetes patients.CLINICAL TRIAL REGISTRATION: NCT02592824, https://clinicaltrials.gov/ct2/show/NCT02592824.PMID:37657522 | DOI:10.1016/j.ajcnut.2023.08.012
Source: The American Journal of Clinical Nutrition - Category: Nutrition Authors: Jonas Holm Farkas Vanky Rolf Svedjeholm Source Type: research
More News: Brain | Cardiology | Clinical Trials | Coronary Artery Bypass Graft | Diabetes | Endocrinology | Heart | Heart Valve Surgery | Insulin | Neurology | Nutrition | Parenteral Nutrition | Stroke